Terms: = Colorectal cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Prognosis
8 results:
1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
2. EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
Chen J; Hong JH; Huang Y; Liu S; Yin J; Deng P; Sun Y; Yu Z; Zeng X; Xiao R; Chan JY; Guan P; Wang Y; Wang P; Liu L; Wen S; Yu Q; Ong CK; Teh BT; Xiong Y; Tan J
Mol Cancer; 2023 May; 22(1):85. PubMed ID: 37210576
[TBL] [Abstract] [Full Text] [Related]
3. Flotillin-1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment.
Wang R; Chen Z; Zhang Y; Xiao S; Zhang W; Hu X; Xiao Q; Liu Q; Wang X
J Cell Mol Med; 2023 Feb; 27(3):392-402. PubMed ID: 36647700
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of the Prognostic Value and Molecular Function of CRNDE in Glioma at Bulk and Single-Cell Levels.
Song L; Li X; Xu X; Huo X; Zheng Y; Wang X; Li D; Zhang J; Wang K; Wang L; Wu Z
Cells; 2022 Nov; 11(22):. PubMed ID: 36429098
[TBL] [Abstract] [Full Text] [Related]
5. Differential expression of the BCAT isoforms between breast cancer subtypes.
Shafei MA; Flemban A; Daly C; Kendrick P; White P; Dean S; Qualtrough D; Conway ME
Breast Cancer; 2021 May; 28(3):592-607. PubMed ID: 33367952
[TBL] [Abstract] [Full Text] [Related]
6. RIPK3 is a novel prognostic marker for lower grade glioma and further enriches idh mutational status subgrouping.
Vergara GA; Eugenio GC; Malheiros SMF; Victor EDS; Weinlich R
J Neurooncol; 2020 May; 147(3):587-594. PubMed ID: 32222932
[TBL] [Abstract] [Full Text] [Related]
7. Mathematical analysis predicts imbalanced idh1/2 expression associates with 2-HG-inactivating β-oxygenation pathway in colorectal cancer.
Koseki J; Colvin H; Fukusumi T; Nishida N; Konno M; Kawamoto K; Tsunekuni K; Matsui H; Doki Y; Mori M; Ishii H
Int J Oncol; 2015 Mar; 46(3):1181-91. PubMed ID: 25586680
[TBL] [Abstract] [Full Text] [Related]
8. The CpG island methylator phenotype: what's in a name?
Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
[TBL] [Abstract] [Full Text] [Related]
